top of page

“More Than a Ticket. It’s Your Seat at the Table.”

Join a private forum where purpose meets progress. At GBX, expect powerful conversations, trusted connections and the space to shape what’s next. No distractions - just the people, ideas and momentum that move industries forward.

17th Annual Bio Innovation Leaders Summit 2025

12th & 13th February 2025
Raffles Singapore

PAST SPEAKERS

GBX_Icon.png
Judy-031-Edit_medium_edited.png

Judy Chou

President and CEO of AltruBio

GBX_Icon.png
Uwe Gottschalk, Operating Partner at Keensight Capital #BILS

Uwe Gottschalk

Operating Partner at Keensight Capital

GBX_Icon.png
Nuno Fontes_edited.png

Nuno Fontes

SVP, Head of Global CMC at WuXi Biologics

Jens H. Vogel

SVP & Head of Global Biologics Operating Unit, Merck & Co

Jens H. Vogel, Previous SVP & Global Biotech at Bayer is an advisor of The 17th Annual Bio Innovation Leaders Summit #BILS 2025 which is taking place in the Raffles Singapore on the 12th & 13th of February 2025

Uwe Gottschalk

Operating Partner at Keensight Capital - Former CSO of Lonza

Uwe Gottschalk, Operating Partner at Keensight Capital - Previous CSO of Lonza is an advisor of The 17th Annual Bio Innovation Leaders Summit #BILS 2025 which is taking place in the Raffles Singapore on the 12th & 13th of February 2025

Jesse McCool

CSO of Bionova Scientific - Co-Founder & former CEO of Wheeler Bio

Jesse McCool, Co-Founder & CEO of Wheeler Bio is an advisor of The 17th Annual Bio Innovation Leaders Summit #BILS 2025 which is taking place in the Raffles Singapore on the 12th & 13th of February 2025

Angela Vollstedt

Global R&D Director Cell & Gene Therapies Portfolio at Novartis

Angela Vollstedt, Global Director, Cell & Gene Therapies Portfolio Management at Novartis is an advisor of The 17th Annual Bio Innovation Leaders Summit #BILS 2025 which is taking place in the Raffles Singapore on the 12th & 13th of February 2025
Behzad Mahdavi, CEO & Board Member at InnoGi Technologies #BILS is an advisor of The 17th Annual Bio Innovation Leaders Summit #BILS 2025 which is taking place in the Raffles Singapore on the 12th & 13th of February 2025

Behzad Mahdavi

CEO & Board member at InnoGI Technologies & Executive Chairman at Open Cell Technologies

DDIF

CGTI

BILS

MEVO

SCIS

CLUB

Uwe Gottschalk, Operating Partner at Keensight Capital - Previous CSO of Lonza speaking at The 17th Annual Bio Innovation Leaders Summit #BILS 2025 which is taking place in the Raffles Singapore on the 12th & 13th of February 2025
BILS_2026_logo
For the patients, we must do better.

18th Annual Bio Innovation Leaders Summit 2026

11th & 12th February 2026
London (exact location TBC)

Co-Located 4th Annual Meat Evolution Leaders Summit #MEVO

The Private Forum for Biomanufacturing Leaders Who Refuse to Wait for the Future

BILS 2026 is closed-door forum for those entrusted with one of the most complex challenges in life sciences: reimagining how we manufacture biology - at speed, at scale and with global purpose.

This gathering is purpose-built for global decision-makers in biologics, bioprocessing, digital manufacturing, CMC and strategic partnerships. It’s where scientific vision and operational reality meet - and where real systems are shaped, refined and redefined.

Whether you're overseeing global biologics capacity, navigating tech transfer, scaling a next-gen therapeutic, integrating smart factory systems or leading platform innovation, this is where you step forward.

Not to attend - but to lead, connect and act.

CURRENT ​SPEAKERS 

A picture of staff at The 17th Annual Bio Innovation Leaders Summit #BILS 2025 which is taking place in the Raffles Singapore on the 12th & 13th of February 2025

SUMMIT INSIGHTS

Who Attends

  • Global VP, Biologics Manufacturing

  • VP, Process Development & MSAT

  • VP, Digital Manufacturing & Automation

  • VP, CMC & Technical Development

  • VP, Quality & Regulatory Affairs - Bioproduction

  • VP, External Manufacturing & Strategic Partnerships

  • COO - CSO - Head of Biomanufacturing Strategy

  • Designing intelligent, responsive manufacturing systems

  • Transitioning from batch to continuous and modular infrastructure

  • Scaling platforms for mRNA, CGT and novel biologics

  • Tech transfer transformation and CMC acceleration

  • Digital twins, AI and automation in bioproduction

  • Quality-by-design and global GMP readiness

  • Sustainability as infrastructure, not initiative

Two Industries. One Biosphere. Unlimited Collaboration.

MEVO 2026, the leading forum for cultivated meat and precision fermentation.

  • This unique convergence creates powerful opportunities:

  • Shared technologies (bioreactors, single-use systems, downstream purification)

  • Cross-sector insights into scale-up, validation and regulatory fluency

  • Direct access to new partnership pathways between pharma, food and synthetic biology

GBX ICON PURPLE_edited_edited_edited.png
Joshi Venugopal, GM & Head of Europe at Novartis Gene Therapies & Rare Diseases #BILS

Joshi Venugopal

GM & Head of Europe

Novartis Gene Therapies & Rare Diseases

GBX ICON PURPLE_edited_edited_edited.png
Dorothee Ambrosius.png

Dorothee Ambrosius

Former Head of CMC Strategy Biologicals

Boehringer Ingelheim

GBX ICON PURPLE_edited_edited_edited.png
Warner Biddle, Previous Global Head of Commercial at Kite, a Gilead Company #BILS_edited.p

Warner Biddle

Former Global Head of Commercial

Kite, a Gilead Company

GBX_Icon.png
Gwendolyn Binder, President, Science & Technology at Cabaletta Bio #BILS_edited.png

Gwendolyn Binder

President of Science & Technology

Cabaletta Bio

GBX_Icon.png
Pierre Caloz, COO of uniQure #BILS

Pierre Caloz

COO

uniQure

GBX_Icon.png
Paolo Martini, Previous CSO of Moderna #BILS_edited.png

Paolo Martini

Former CSO

Moderna

GBXEVENTS2024

IN PERSON ONLY

​Unmatched peer exchange with up to 200 qualified executives tackling shared challenges in speed, quality and sustainability

SUMMIT
INSIGHTS

Our Mission

Our purpose is to create a gathering that empowers and inspires critical decision-making; sparking new opportunities to amplify their impact within the biologics and cell and gene therapy value chain.

We encourage collaboration and innovation, which is why this summit ensures that each participant contributes significantly to advancing the field. It serves as a platform for sharing insights, fostering partnerships and driving forward the next wave of breakthroughs in biologics.

For the patients, we must do better. 

Click to view testimonials

Investors and large biopharma companies need to satisfy environmental compliance. We will keynote the progression toward more sustainable bioprocesses, manufacturing and supply methods, amalgamating toward building a sustainable and digitised ecosystem - an emerging frontier of digitisation and industry 4.0.

Closing session by Merck.

Attendee Profile

C-Suite - Directors - Executives

Bioprocess - Manufacturing - IT-Data Integration - Commercial and Business Development - Scientists - Supply Chain - Production - PAT

 

Focus Area 

CGT

Antibody Drugs 

Vaccine

Small molecule, conjugates and peptides 

Technology or Service Companies

CRO

CDMO

Biologic workflow solutions

Advance Bioprocessing 

End to end workflow solutions

Digitising - AI - Data

Automation - Robotics

Filtration - Single use - Bioreactors

Event highlights

Pre Event Innovation Tour - Private Innovation Tour - CXO

Please click to Tour 2024

Evening of day one -Private Networking Dinner 

Journey of a CXO

Exclusive closed-door talks from some of the most prominent leaders in the industry who will be talking about their journey, lessons learnt and vision for the future.

Attendance Guide

30% Asian Biopharma

25% International Biopharma

20% CMOs - CDMOS's

15% Academic & Research Institutes

10% Technology & Service Providers

Curated Meetings

Packages have sold out

Guaranteed pre-qualified strategy meetings 

Prior contact

Mutual benefit

Conducted by our specialists

Geography

25% Korea & Japan

20% Singapore

20% Indonesia, Thailand, Philippines, Malaysia, India & Australia

15% China, Hong Kong & Taiwan

15% USA

5% UAE

PREVIOUS SPEAKERS

Jens H. Vogel, SVP & Global Head of Biotech at Bayer speaking at The 17th Annual Bio Innovation Leaders Summit #BILS 2025 which is taking place in the Raffles Singapore on the 12th & 13th of February 2025

This is where the scientific promise of novel therapies meets the operational reality of delivering them - safely, efficiently and globally.

ADVISORY

Join BILS 2026 to shape the next decade of biologics manufacturing

GBXEVENTS2024_Staff

Subscribe to Our Mailing List

bottom of page